Theoretical and Class-Level Risks These have not been confirmed in cagrilintide trials but are flagged because they appear in related amylin or GLP-1 class data: pancreatitis, gallbladder disease, severe hypoglycemia (mainly when combined with insulin or sulfonylureas), and acute kidney injury secondary to dehydration from severe nausea or vomiting
doi:10.1590/s0004-27302011000800009
10.1155/2015/171742 71 LamontB
divided TNBC into six subtypes from the molecular classification: basal-like 1/2, immune modulative, mesenchymal, mesenchymal stem cell-like, and luminal androgen receptor subtypes, 128 and subsequently Burstein et al
Individual factors like genetic predisposition, metabolism, and GLP-1 receptor sensitivity influence how effectively a particular dose works for your body
Systemic TDZ are unlikely to advance as a therapeutic intervention for asthma due to these safety concerns and the lack of clinical benefit